Evidence map›Paper›PMID 29476359›Full record

ArticleMolecular and cellular biochemistry2018

Type 1 diabetes mellitus induces structural changes and molecular remodelling in the rat kidney.

Raphael M Singh, Frank C Howarth, Ernest Adeghate, Keshore Bidasee, Jaipaul Singh, Tehreem Waqar

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Adenosine ACells · 2025
    Article
  3. Article
  4. Research on TCM Comprehensive Treatment of DKD Based on Pathophysiological Mechanism.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Review
  5. Effect ofInternational journal of molecular sciences · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Arsenic exposure intensifies glycogen nephrosis in diabetic rats.Environmental science and pollution research international · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Raphael M SinghSchool of Forensic and Applied Sciences, University of Central Lancashire, Preston, England, PR1 2HE, UK. raphael_singh@yahoo.com.
Frank C HowarthDepartment of Physiology and College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Ernest AdeghateDepartment of Human Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Keshore BidaseeDepartment of Pharmacology and Experimental Neurosciences, University of Nebraska Medical Centre, Omaha, NE, 68198, USA.
Jaipaul SinghSchool of Forensic and Applied Sciences, University of Central Lancashire, Preston, England, PR1 2HE, UK.
Tehreem WaqarSchool of Forensic and Applied Sciences, University of Central Lancashire, Preston, England, PR1 2HE, UK.
University of Central Lancashire · GBUnited Arab Emirates University · AEUniversity of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is much evidence that diabetes mellitus (DM)-induced hyperglycemia (HG) is responsible for kidney failure or nephropathy leading to cardiovascular complications. Cellular and molecular mechanism(s) whereby DM can damage the kidney is still not fully understood. This study investigated the effect of streptozotocin (STZ)-induced diabetes (T1DM) on the structure and associated molecular alterations of the isolated rat left kidney following 2 and 4 months of the disorder compared to the respective age-matched controls. The results revealed hypertrophy and general disorganized architecture of the kidney characterized by expansion in glomerular borders, tubular atrophy and increased vacuolization of renal tubular epithelial cells in the diabetic groups compared to controls. Electron microscopic analysis revealed ultrastructural alterations in the left kidney highlighted by an increase in glomerular basement membrane width. In addition, increased caspase-3 immunoreactivity was observed in the kidney of T1DM animals compared to age-matched controls. These structural changes were associated with elevated extracellular matrix (ECM) deposition and consequently, altered gene expression profile of ECM key components, together with elevated levels of key mediators (MMP9, integrin 5α, TIMP4, CTGF, vimentin) and reduced expressions of Cx43 and MMP2 of the ECM. Marked hypertrophy of the kidney was highlighted by increased atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) gene expression. These changes also correlated with increased TGFβ1 activity, gene expression in the left kidney and elevated active TGFβ1 in the plasma of T1DM rats compared to control. The results clearly demonstrated that TIDM could elicit severe structural changes and alteration in biochemical markers (remodelling) in the kidney leading to diabetic nephropathy (DN).

Indexed as

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Extracellular MatrixGlomerular Basement MembraneAnimalsAtrial Natriuretic FactorCaspase 3Extracellular Matrix ProteinsGene Expression RegulationMaleNatriuretic Peptide, BrainRatsRats, WistarTransforming Growth Factor beta1Atrial Natriuretic FactorCasp3 protein, ratCaspase 3Extracellular Matrix ProteinsNatriuretic Peptide, BrainTgfb1 protein, ratTransforming Growth Factor beta1ApoptosisDiabetes-induced nephropathyFibrosisGene expressionTransforming growth factor β1 (TGFβ1)Type 1 diabetes

Identifiers

PMID29476359
OpenAlexW2788443776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.